Abstract
The fields of biomedical nanotechnology and theranostics have enjoyed exponential growth in recent years. The “Molecular Imaging in Nanotechnology and Theranostics” (MINT) Interest Group of the World Molecular Imaging Society (WMIS) was created in order to provide a more organized and focused forum on these topics within the WMIS and at the World Molecular Imaging Conference (WMIC). The interest group was founded in 2015 and was officially inaugurated during the 2016 WMIC. The overarching goal of MINT is to bring together the many scientists who work on molecular imaging approaches using nanotechnology and those that work on theranostic agents. MINT therefore represents scientists, labs, and institutes that are very diverse in their scientific backgrounds and areas of expertise, reflecting the wide array of materials and approaches that drive these fields. In this short review, we attempt to provide a condensed overview over some of the key areas covered by MINT. Given the breadth of the fields and the given space constraints, we have limited the coverage to the realm of nanoconstructs, although theranostics is certainly not limited to this domain. We will also focus only on the most recent developments of the last 3–5 years, in order to provide the reader with an intuition of what is “in the pipeline” and has potential for clinical translation in the near future.
Similar content being viewed by others
References
Bobo D, Robinson KJ, Islam J et al (2016) Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res 33:2373–2387
Anselmo AC, Mitragotri S (2016) Nanoparticles in the clinic. Bioeng Translational Med 1:10–29
Stylianopoulos T (2016) Intelligent drug delivery systems for the treatment of solid tumors. Eur J Nanomed 8:9–16
Kircher MF, Willmann JK (2012) Molecular body imaging: MR imaging, CT, and US. Part II. Applications. Radiology 264:349–368
Kircher MF, Willmann JK (2012) Molecular body imaging: MR imaging, CT, and US. Part I. Principles. Radiology 263:633–643
Bashir MR, Bhatti L, Marin D, Nelson RC (2015) Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging 41:884–898
Gaglia JL, Harisinghani M, Aganj I et al (2015) Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients. Proc Natl Acad Sci U S A 112:2139–2144
Kirschbaum K, Sonner JK, Zeller MW et al (2016) In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proc Natl Acad Sci U S A 113:13227–13232
Deng L, Stafford JH, Liu SC et al (2016) SDF-1 blockade enhances anti-VEGF therapy of glioblastoma and can be monitored by MRI. Neoplasia 19:1–7
Bryant LH Jr, Kim SJ, Hobson M et al (2016) Physicochemical characterization of ferumoxytol, heparin and protamine nanocomplexes for improved magnetic labeling of stem cells. Nanomedicine. doi:10.1016/j.nano.2016.07.011
Klenk C, Gawande R, Uslu L et al (2014) Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study. Lancet Oncol 15:275–285
Zanganeh S, Hutter G, Spitler R et al (2016) Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nano 11:986–994
Pratt EC, Shaffer TM, Grimm J (2016) Nanoparticles and radiotracers: advances toward radionanomedicine. Wiley interdisciplinary reviews Nanomedicine and nanobiotechnology 8:872–890
Lee DS, Im H-J, Lee Y-S (2015) Radionanomedicine: widened perspectives of molecular theragnosis. Nanomedicine: Nanotechnology, Bio Med 11:795–810
Goel S, Chen F, Ehlerding EB, Cai W (2014) Intrinsically radiolabeled nanoparticles: an emerging paradigm. Small 10:3825–3830
Sun X, Huang X, Yan X et al (2014) Chelator-free 64Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy. ACS Nano 8:8438–8446
Zhao Y, Sultan D, Detering L et al (2014) Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. Angew Chem Intl Ed 53:156–159
Guo W, Sun X, Jacobson O et al (2015) Intrinsically radioactive [64Cu]CuInS/ZnS quantum dots for PET and optical imaging: improved radiochemical stability and controllable Cerenkov luminescence. ACS Nano 9:488–495
Sun X, Huang X, Guo J et al (2014) Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging. J Am Chem Soc 136:1706–1709
Shaffer TM, Harmsen S, Khwaja E et al (2016) Stable radiolabeling of sulfur-functionalized silica nanoparticles with copper-64. Nano Lett 16:5601–5604
Pressly ED, Pierce RA, Connal LA et al (2013) Nanoparticle PET/CT imaging of natriuretic peptide clearance receptor in prostate cancer. Bioconj Chem 24:196–204
Gao F, Cai P, Yang W et al (2015) Ultrasmall [64Cu]Cu nanoclusters for targeting orthotopic lung tumors using accurate positron emission tomography imaging. ACS Nano 9:4976–4986
Hansen AE, Petersen AL, Henriksen JR et al (2015) Positron emission tomography based elucidation of the enhanced permeability and retention effect in dogs with cancer using copper-64 liposomes. ACS Nano 9:6985–6995
Madru R, Tran TA, Axelsson J et al (2014) 68Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes. Am J Nucl Med Mol Imaging 4:60–69
Frigell J, Garcia I, Gomez-Vallejo V, Llop J, Penades S (2014) 68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. J Am Chem Soc 136:449–457
Thorek DL, Ulmert D, Diop NF et al (2014) Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle. Nat Commun 5:3097
Shaffer TM, Wall MA, Harmsen S et al (2015) Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes. Nano Lett 15:864–868
Zeng J, Jia B, Qiao R et al (2014) In situ 111In-doping for achieving biocompatible and non-leachable 111In-labeled Fe3O4 nanoparticles. Chem Commun 50:2170–2172
Shukla R, Chanda N, Zambre A et al (2012) Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci 109:12426–12431
Black KCL, Wang Y, Luehmann HP et al (2014) Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution. ACS Nano 8:4385–4394
Majmudar MD, Yoo J, Keliher EJ et al (2013) Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res 112:755–61
Perez-Medina C, Tang J, Abdel-Atti D et al (2015) PET imaging of tumor-associated macrophages with 89Zr-labeled high-density lipoprotein nanoparticles. J Nucl Med 56:1272–1277
Keliher EJ, Yoo J, Nahrendorf M et al (2011) 89Zr labeled dextran nanoparticles enable in vivo macrophage imaging. Bioconj Chem 22:2383–2389
Benezra M, Penate-Medina O, Zanzonico PB et al (2011) Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 121:2768–2780
Phillips E, Penate-Medina O, Zanzonico PB et al (2014) Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci Transl Med 6:260ra149–260ra149
Hill TK, Mohs AM (2016) Image-guided tumor surgery: will there be a role for fluorescent nanoparticles? Wiley interdisciplinary reviews Nanomed Nanobiotechnol 8:498–511
Kamila S, McEwan C, Costley D et al (2016) Diagnostic and therapeutic applications of quantum dots in nanomedicine. Top Curr Chem 370:203–224
Wang Y, Zhou K, Huang G et al (2014) A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals. Nat Mater 13:204–212
Priem B, Tian C, Tang J, Zhao Y, Mulder WJ (2015) Fluorescent nanoparticles for the accurate detection of drug delivery. Expert Opin Drug Deliv 12:1881–1894
Nune SK, Gunda P, Thallapally PK et al (2009) Nanoparticles for biomedical imaging. Expert Opin Drug Deliv 6:1175–1194
Wu C, Bull B, Szymanski C et al (2008) Multicolor conjugated polymer dots for biological fluorescence imaging. ACS Nano 2:2415–2423
Sample V, Newman RH, Zhang J (2009) The structure and function of fluorescent proteins. Chem Soc Rev 38:2852–2864
Yang J, Zhang Y, Gautam S et al (2009) Development of aliphatic biodegradable photoluminescent polymers. Proc Natl Acad Sci U S A 106:10086–10091
Zhao Y, Ye M, Chao Q et al (2009) Simultaneous detection of multifood-borne pathogenic bacteria based on functionalized quantum dots coupled with immunomagnetic separation in food samples. J Agric Food Chem 57:517–524
Yan L, Zhang Y, Xu B, Tian W (2016) Fluorescent nanoparticles based on AIE fluorogens for bioimaging. Nanoscale 8:2471–2487
Geng J, Zhu Z, Qin W et al (2014) Near-infrared fluorescence amplified organic nanoparticles with aggregation-induced emission characteristics for in vivo imaging. Nanoscale 6:939–945
Tummers QR, Hoogstins CE, Peters AA et al (2015) The value of intraoperative near-infrared fluorescence imaging based on enhanced permeability and retention of indocyanine green: feasibility and false-positives in ovarian cancer. PLoS One 10:e0129766
Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401
Andreou C, Kishore SA, Kircher MF (2015) Surface-enhanced Raman spectroscopy: a new modality for cancer imaging. J Nucl Med 56:1295–1299
Andreou C, Neuschmelting V, Tschaharganeh D-F et al (2016) Imaging of liver tumors using surface-enhanced Raman scattering nanoparticles. ACS Nano 10:5015–5026
Garai E, Sensarn S, Zavaleta CL et al (2013) High-sensitivity, real-time, ratiometric imaging of surface-enhanced Raman scattering nanoparticles with a clinically translatable Raman endoscope device. J Biomed Opt 18:096008
Harmsen S, Huang R, Wall MA et al (2015) Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging. Sci Transl Med 7:271ra277
Spaliviero M, Harmsen S, Huang R et al (2016) Detection of lymph node metastases with SERRS nanoparticles. Mol Imaging Biol 18:677–685
Kircher MF, de la Zerda A, Jokerst JV et al (2012) A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 18:829–834
Harmsen S, Bedics MA, Wall MA et al (2015) Rational design of a chalcogenopyrylium-based surface-enhanced resonance Raman scattering nanoprobe with attomolar sensitivity. Nat Commun 6:6570
Huang R, Harmsen S, Samii JM et al (2016) High precision imaging of microscopic spread of glioblastoma with a targeted ultrasensitive SERRS molecular imaging probe. Theranostics 6:1075–1084
Karabeber H, Huang R, Iacono P et al (2014) Guiding brain tumor resection using surface-enhanced Raman scattering nanoparticles and a hand-held Raman scanner. ACS Nano 8:9755–9766
Oseledchyk A, Andreou C, Wall MA, Kircher MF (2017) Folate-targeted surface-enhanced resonance Raman scattering nanoprobe Ratiometry for detection of microscopic ovarian cancer. ACS Nano. doi:10.1021/acsnano.6b06796
Nayak TR, Andreou C, Oseledchyk A et al (2016) Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastases. Nanoscale. doi:10.1039/C6NR08217C
Lemaster JE, Jokerst JV (2016) What is new in nanoparticle-based photoacoustic imaging? Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol. doi:10.1002/wnan.1404
Cheheltani R, Ezzibdeh RM, Chhour P et al (2016) Tunable, biodegradable gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging. Biomaterials 102:87–97
Cheng X, Sun R, Yin L et al (2016) Light-triggered assembly of gold nanoparticles for photothermal therapy and photoacoustic imaging of tumors in vivo. Adv Mater. doi:10.1002/adma.201604894
Dixon AJ, Hu S, Klibanov AL, Hossack JA (2015) Oscillatory dynamics and in vivo photoacoustic imaging performance of plasmonic nanoparticle-coated microbubbles. Small 11:3066–3077
Jing L, Liang X, Deng Z et al (2014) Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials 35:5814–5821
Liu Y, He J, Yang K et al (2015) Folding up of gold nanoparticle strings into plasmonic vesicles for enhanced photoacoustic imaging. Angew Chem 127:16035–16038
Yang H-W, Liu H-L, Li M-L et al (2013) Magnetic gold-nanorod/PNIPAAmMA nanoparticles for dual magnetic resonance and photoacoustic imaging and targeted photothermal therapy. Biomaterials 34:5651–5660
Egusquiaguirre SP, Beziere N, Pedraz JL et al (2015) Optoacoustic imaging enabled biodistribution study of cationic polymeric biodegradable nanoparticles. Contrast Media Mol Imaging 10:421–427
Jokerst JV, Van de Sompel D, Bohndiek SE, Gambhir SS (2014) Cellulose nanoparticles are a biodegradable photoacoustic contrast agent for use in living mice. Photoacoustics 2:119–127
Li K, Liu B (2014) Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging. Chem Soc Rev 43:6570–6597
Lu HD, Wilson BK, Heinmiller A et al (2016) Narrow absorption NIR wavelength organic nanoparticles enable multiplexed photoacoustic imaging. ACS Applied Mater Interfaces 8:14379–14388
Xie C, Upputuri PK, Zhen X et al (2017) Self-quenched semiconducting polymer nanoparticles for amplified in vivo photoacoustic imaging. Biomaterials 119:1–8
Yan Y, Yang Q, Wang J et al (2017) Heteropoly blue doped polymer nanoparticles: an efficient theranostic agent for targeted photoacoustic imaging and near-infrared photothermal therapy in vivo. J Mater Chem B 5:382–387
Maji SK, Sreejith S, Joseph J et al (2014) Upconversion nanoparticles as a contrast agent for photoacoustic imaging in live mice. Adv Mater 26:5633–5638
Cai X, Liu X, Liao LD et al (2016) Encapsulated conjugated oligomer nanoparticles for real-time photoacoustic sentinel lymph node imaging and targeted photothermal therapy. Small 12:4873–4880
Chen Q, Liu X, Zeng J et al (2016) Albumin-NIR dye self-assembled nanoparticles for photoacoustic pH imaging and pH-responsive photothermal therapy effective for large tumors. Biomaterials 98:23–30
Ding K, Zeng J, Jing L et al (2015) Aqueous synthesis of PEGylated copper sulfide nanoparticles for photoacoustic imaging of tumors. Nanoscale 7:11075–11081
Gao S, Wang G, Qin Z et al (2017) Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy. Biomaterials 112:324–335
Ho I-T, Sessler JL, Gambhir SS, Jokerst JV (2015) Parts per billion detection of uranium with a porphyrinoid-containing nanoparticle and in vivo photoacoustic imaging. Analyst 140:3731–3737
Jin Y, Li Y, Ma X et al (2014) Encapsulating tantalum oxide into polypyrrole nanoparticles for X-ray CT/photoacoustic bimodal imaging-guided photothermal ablation of cancer. Biomaterials 35:5795–5804
Ku G, Zhou M, Song S et al (2012) Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064 nm. ACS Nano 6:7489–7496
Liu R, Jing L, Peng D et al (2015) Manganese (II) chelate functionalized copper sulfide nanoparticles for efficient magnetic resonance/photoacoustic dual-modal imaging guided photothermal therapy. Theranostics 5:1144–1153
Lyu Y, Fang Y, Miao Q et al (2016) Intraparticle molecular orbital engineering of semiconducting polymer nanoparticles as amplified theranostics for in vivo photoacoustic imaging and photothermal therapy. ACS Nano 10:4472–4481
Pu K, Mei J, Jokerst JV et al (2015) Diketopyrrolopyrrole-based semiconducting polymer nanoparticles for in vivo photoacoustic imaging. Adva Mater 27:5184–5190
Pu K, Shuhendler AJ, Jokerst JV et al (2014) Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice. Nature Nanotechnol 9:233–239
Sun C, Wen L, Zeng J et al (2016) One-pot solventless preparation of PEGylated black phosphorus nanoparticles for photoacoustic imaging and photothermal therapy of cancer. Biomaterials 91:81–89
Tsyboulski DA, Liopo AV, Su R et al (2014) Enabling in vivo measurements of nanoparticle concentrations with three-dimensional optoacoustic tomography. J Biophotonics 7:581–588
Yu J, Yang C, Li J et al (2014) Multifunctional Fe5C2 nanoparticles: a targeted theranostic platform for magnetic resonance imaging and photoacoustic tomography-guided photothermal therapy. Adv Mater 26:4114–4120
Bogdanov AA Jr, Dixon AJ, Gupta S et al (2016) Synthesis and testing of modular dual-modality nanoparticles for magnetic resonance and multispectral photoacoustic imaging. Bioconjug Chem 27:383–390
Grootendorst DJ, Jose J, Fratila RM et al (2013) Evaluation of superparamagnetic iron oxide nanoparticles (Endorem®) as a photoacoustic contrast agent for intra-operative nodal staging. Contrast Media Mol Imaging 8:83–91
Xi L, Grobmyer SR, Zhou G et al (2014) Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents. J Biophotonics 7:401–409
Gurka MK, Pender D, Chuong P et al (2016) Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. J Control Release 231:60–67
Li J, Arnal B, Wei C-W et al (2015) Magneto-optical nanoparticles for cyclic magnetomotive photoacoustic imaging. ACS Nano 9:1964–1976
Das S, Thorek DLJ, Grimm J (2014) Cerenkov imaging. Adv Cancer Res 124:213–234
Thorek DL, Riedl CC, Grimm J (2014) Clinical Cerenkov luminescence imaging of 18F-FDG. J Nucl Med 55:95–98
Czupryna J, Kachur AV, Blankemeyer E et al (2015) Cerenkov-specific contrast agents for detection of pH in vivo. J Nucl Med 56:483–488
Grootendorst MR, Cariati M, Kothari A et al (2016) Cerenkov luminescence imaging (CLI) for image-guided cancer surgery. Clin Translational Imaging 4:353–366
Kotagiri N, Sudlow G, Akers W, Achilefu S (2015) Depth-independent phototherapy using Cerenkov radiation and titanium dioxide nanoparticles. J Nucl Med 56:643–643
Black KCL, Ibricevic A, Gunsten SP et al (2016) In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Ĉerenkov imaging. Biomaterials 98:53–63
Kamkaew A, Cheng L, Goel S et al (2016) Cerenkov radiation induced photodynamic therapy using Chlorin e6-loaded hollow mesoporous silica nanoparticles. ACS Applied Mater Interfaces 8:26630–26637
Lee SB, Ahn SB, Lee SW et al (2016) Radionuclide-embedded gold nanoparticles for enhanced dendritic cell-based cancer immunotherapy, sensitive and quantitative tracking of dendritic cells with PET and Cerenkov luminescence. NPG Asia Materials 8:e281
Lee SB, Yoon G, Lee SW et al (2016) Combined positron emission tomography and Cerenkov luminescence imaging of sentinel lymph nodes using PEGylated radionuclide-embedded gold nanoparticles. Small 12:4894–4901
Hu Z, Qu Y, Wang K et al (2015) In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging. Nature Commun 6:7560
Thorek DL, Ogirala A, Beattie BJ, Grimm J (2013) Quantitative imaging of disease signatures through radioactive decay signal conversion. Nat Med 19:1345–1350
Xu R, Zhang G, Mai J et al (2016) An injectable nanoparticle generator enhances delivery of cancer therapeutics. Nat Biotech 34:414–418
Zhang R, Fan Q, Yang M et al (2015) Engineering melanin nanoparticles as an efficient drug-delivery system for imaging-guided chemotherapy. Adv Mater 27:5063–5069
Yan Y, Liu L, Xiong H et al (2016) Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells. Proc Natl Acad Sci U S A 113:E5702–E5710
Zheng D, Giljohann DA, Chen DL et al (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci U S A 109:11975–11980
Alidori S, Akhavein N, Thorek DLJ et al (2016) Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury. Sci Translational Med 8:331ra339
Gobin AM, Lee MH, Halas NJ et al (2007) Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 7:1929–1934
Stern JM, Stanfield J, Kabbani W et al (2008) Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urology 179:748–753
Schwartz JA, Shetty AM, Price RE et al (2009) Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model. Cancer Res 69:1659
Loo C, Lowery A, Halas N et al (2005) Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 5:709–711
Cardinal J, Klune JR, Chory E et al (2008) Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery 144:125–132
Gannon CJ, Patra CR, Bhattacharya R et al (2008) Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnol 6:2
Kotagiri N, Sudlow GP, Akers WJ, Achilefu S (2015) Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat Nano 10:370–379
Idris NM, Gnanasammandhan MK, Zhang J et al (2012) In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med 18:1580–1585
Maier-Hauff K, Ulrich F, Nestler D et al (2011) Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neuro-Oncol 103:317–324
Johannsen M, Gneveckow U, Taymoorian K et al (2007) Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. International J Hyperthermia 23:315–323
van Landeghem FKH, Maier-Hauff K, Jordan A et al (2009) Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30:52–57
Hayashi K, Nakamura M, Sakamoto W et al (2013) Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics 3:366–376
Jordan A, Scholz R, Maier-Hauff K et al (2006) The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neuro-Oncol 78:7–14
Kalber TL, Ordidge KL, Southern P et al (2016) Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles. Int J Nanomedicine 11:1973–1983
Timbie K, Nance E, Zhang C, et al. (2014) Ultrasound-mediated nanoparticle delivery across the blood-brain barrier (676.17). FASEB J (suppl 676.17) 28
Rapoport N, Payne A, Dillon C et al (2013) Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. J Ther Ultrasound 1:11
Morch Y, Hansen R, Berg S et al (2015) Nanoparticle-stabilized microbubbles for multimodal imaging and drug delivery. Contrast Media Mol Imaging 10:356–366
Min HS, Son S, You DG et al (2016) Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery. Biomaterials 108:57–70
Stephan MT, Moon JJ, Um SH et al (2010) Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med 16:1035–1041
Chen Q, Xu L, Liang C et al (2016) Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun 7:13193
Fadel TR, Sharp FA, Vudattu N et al (2014) A carbon nanotube–polymer composite for T-cell therapy. Nat Nano 9:639–647
McLaughlin MF, Robertson D, Pevsner PH et al (2014) LnPO4 nanoparticles doped with Ac-225 and sequestered daughters for targeted alpha therapy. Cancer Biother Radiopharmac 29:34–41
McLaughlin MF, Woodward J, Boll RA et al (2013) Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy. PLoS One 8:e54531
Chen J, Zhu S, Tong L et al (2014) Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice. BMC Cancer 14:114–114
Klutz K, Schaffert D, Willhauck MJ et al (2011) Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene. Mol Therapy 19:676–685
Satterlee AB, Yuan H, Huang L (2015) A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging. J Control Release 217:170–182
Das M, Datir SR, Singh RP, Jain S (2013) Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic acid-multiwalled carbon nanotube conjugate. Mol Pharmac 10:2543–2557
Zhang X-D, Luo Z, Chen J et al (2014) Ultrasmall Au10–12(SG)10–12 nanomolecules for high tumor specificity and cancer radiotherapy. Adv Mater 26:4565–4568
Al Zaki A, Joh D, Cheng Z et al (2014) Gold-loaded polymeric micelles for computed tomography-guided radiation therapy treatment and radiosensitization. ACS Nano 8:104–112
Hainfeld JF, Smilowitz HM, O'Connor MJ et al (2013) Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomed 8:1601–1609
Popovtzer A, Mizrachi A, Motiei M et al (2016) Actively targeted gold nanoparticles as novel radiosensitizer agents: an in vivo head and neck cancer model. Nanoscale 8:2678–2685
Liu P, Huang Z, Chen Z et al (2013) Silver nanoparticles: a novel radiation sensitizer for glioma? Nanoscale 5:11829–11836
Moeendarbari S, Tekade R, Mulgaonkar A et al (2016) Theranostic nanoseeds for efficacious internal radiation therapy of unresectable solid tumors. Sci Reports 6:20614
Yi X, Yang K, Liang C et al (2015) Imaging-guided combined photothermal and radiotherapy to treat subcutaneous and metastatic tumors using iodine-131-doped copper sulfide nanoparticles. Adv Functional Mater 25:4689–4699
Chen F, Rieffel J, Chen G et al (2015) Hexamodal imaging in vivo with nanoparticles. J Nucl Med 56:56–56
Rieffel J, Chen F, Kim J et al (2015) Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles. Adv Mater 27:1785–1790
Conde J, Oliva N, Zhang Y, Artzi N (2016) Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat Mater 15:1128–1138
Kaittanis C, Shaffer TM, Bolaender A et al (2015) Multifunctional MRI/PET nanobeacons derived from the in situ self-assembly of translational polymers and clinical cargo through coalescent intermolecular forces. Nano Lett 15:8032–8043
Kaittanis C, Shaffer TM, Ogirala A et al (2014) Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching. Nat Commun 5:3384
Miller MA, Gadde S, Pfirschke C et al (2015) Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Sci Transl Med 7:314ra183–314ra183
van de Ven AL, Abdollahi B, Martinez CJ et al (2013) Modeling of nanotherapeutics delivery based on tumor perfusion. New J Phys 15:55004
Wu L, Cai X, Nelson K et al (2013) A green synthesis of carbon nanoparticles from honey and their use in real-time photoacoustic imaging. Nano Res 6:312–325
Sharma N, Pinnaka AK, Raje M et al (2012) Exploitation of marine bacteria for production of gold nanoparticles. Microb Cell Factories 11:86
Kikuchi F, Kato Y, Furihata K et al (2016) Formation of gold nanoparticles by glycolipids of Lactobacillus casei. Sci Rep 6:34626
Parodi A, Quattrocchi N, van de Ven AL et al (2013) Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 8:61–68
Braun GB, Friman T, Pang HB et al (2014) Etchable plasmonic nanoparticle probes to image and quantify cellular internalization. Nat Mater 13:904–911
Kim SE, Zhang L, Ma K et al (2016) Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat Nano 11:977–985
Li M, Li L, Zhan C, Kohane DS (2016) Core-shell nanostars for multimodal therapy and imaging. Theranostics 6:2306–2313
Chen F, Ellison PA, Lewis CM et al (2013) Chelator-free synthesis of a dual-modality PET/MRI agent. Angewandte Chemie (International ed in English) 52:13319–13323
Chakravarty R, Valdovinos HF, Chen F et al (2014) Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging. Adv Mater 26:5119–5123
Siddiqi KS, Ur Rahman A, Tajuddin HA (2016) Biogenic fabrication of iron/iron oxide nanoparticles and their application. Nanoscale Res Lett 11:498
Tafoya MA, Madi S, Sillerud LO (2016) Superparamagnetic nanoparticle-enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: contrast optimization. J Magn Reson Imaging. doi:10.1002/jmri.25563
Madru R, Tran TA, Axelsson J et al (2013) 68Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes. Am J Nucl Med Mol Imaging 4:60–69
Aghighi M, Golovko D, Ansari C et al (2015) Imaging tumor necrosis with ferumoxytol. PLoS One 10:e0142665
Khurana A, Chapelin F, Beck G et al (2013) Iron administration before stem cell harvest enables MR imaging tracking after transplantation. Radiology 269:186–197
Sciallero C, Balbi L, Paradossi G, Trucco A (2016) Magnetic resonance and ultrasound contrast imaging of polymer-shelled microbubbles loaded with iron oxide nanoparticles. R Soc Open Sci 3:160063
Nissinen T, Nakki S, Laakso H et al (2016) Tailored dual PEGylation of inorganic porous nanocarriers for extremely long blood circulation in vivo. ACS Appl Mater Interfaces 8:32723–32731
Cui Y, Zhang C, Luo R et al (2016) Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles. Int J Nanomedicine 11:5671–5682
Jaidev LR, Chellappan DR, Bhavsar DV et al (2017) Multi-functional nanoparticles as theranostic agents for the treatment & imaging of pancreatic cancer. Acta Biomater 49:422–433
Liu Q, Sun Y, Li C et al (2011) 18F-labeled magnetic-upconversion nanophosphors via rare-earth cation-assisted ligand assembly. ACS Nano 5:3146–3157
Xiang Z, Yang X, Xu J et al (2017) Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide. Biomaterials 115:53–64
Wang Y, Liu Y, Luehmann H et al (2013) Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. Nano Lett 13:581–585
Perez-Campana C, Gomez-Vallejo V, Puigivila M et al (2013) Biodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particles. ACS Nano 7:3498–3505
Perez-Campana C, Gomez-Vallejo V, Martin A et al (2012) Tracing nanoparticles in vivo: a new general synthesis of positron emitting metal oxide nanoparticles by proton beam activation. Analyst 137:4902–4906
Zhou M, Zhang R, Huang M et al (2010) A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J Am Chem Soc 132:15351–15358
Thorek DLJ, Das S, Grimm J (2014) Molecular imaging using nanoparticle quenchers of Cerenkov luminescence. Small 10:3729–3734
Lin X, Xie J, Niu G et al (2011) Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett 11:814–819
Mead BP, Mastorakos P, Suk JS et al (2016) Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound. J Control Release 223:109–117
Ma X, Kang F, Xu F et al (2013) Enhancement of Cerenkov luminescence imaging by dual excitation of Er3+, Yb3+-doped rare-earth microparticles. PLoS One 8:e77926
Zhenhua H, Liu M, Guo H et al (2016) Image-guided cancer surgery using a novel nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging. J Nucl Med 57:59–59
Lee B-R, Ko HK, Ryu JH et al (2016) Engineered human ferritin nanoparticles for direct delivery of tumor antigens to lymph node and cancer immunotherapy. Sci Reports 6:35182
Acknowledgements
We would like to thank the investigators who joined us as Founding Members of the MINT interest group for their valuable contribution to the field. Namely, Silvio Aime, James Basilion, Michelle Bradbury, Heike Daldrup-Link, Katherine Ferrara, Sam Gambir, Jan Grimm, Jesse Jokerst, Kimberly Kelly, Fabian Kiessling, Twan Lammers, Jonathan Liu, Matthias Nahrendorf, Vasilis Ntziachristos, Manuel Perez, Bernd Pichler, Mikhail G. Shapiro, Andrew Tsourkas, and Ralph Weissleder. The following funding sources (to M.F.K.) are acknowledged: NIH R01 EB017748 and K08 CA16396; M.F.K. is a Damon Runyon-Rachleff Innovator supported (in part) by the Damon Runyon Cancer Research Foundation (DRR-29-14); Pershing Square Sohn Prize by the Pershing Square Sohn Cancer Research Alliance; MSKCC Center for Molecular Imaging & Nanotechnology (CMINT) Grant; MSKCC Technology Development Grant; Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research and The Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center. Acknowledgements are also extended to the grant-funding support provided by the MSKCC NIH Core Grant (P30-CA008748).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
M.F.K. is an inventor on several pending patents related to Raman nanoparticles, Raman detection, and theranostic hardware, as well as radiolabeling of silica particles, and is a cofounder of RIO Imaging, Inc., a startup company that has licensed several of these patents.
Rights and permissions
About this article
Cite this article
Andreou, C., Pal, S., Rotter, L. et al. Molecular Imaging in Nanotechnology and Theranostics. Mol Imaging Biol 19, 363–372 (2017). https://doi.org/10.1007/s11307-017-1056-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-017-1056-z